Western-blots detected increased p-STAT3 in these CKS1B-silenced myeloma cells compared with untreated, SCR- or CKS1B-shRNA-transfected controls (Figure 4D), confirming activation of STAT3 in IGF-1-treated cells. This evidence concerns the gene STAT3 and plasma cell myeloma.